Legal & General Group Plc Raises Stake in Intuitive Surgical, Inc. $ISRG

Legal & General Group Plc grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.3% in the third quarter, Holdings Channel reports. The fund owned 2,376,714 shares of the medical equipment provider’s stock after purchasing an additional 141,357 shares during the period. Legal & General Group Plc’s holdings in Intuitive Surgical were worth $1,062,938,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of ISRG. Tobam increased its position in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. Kilter Group LLC acquired a new position in Intuitive Surgical in the 2nd quarter valued at about $27,000. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical during the 3rd quarter valued at approximately $27,000. Caitlin John LLC acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $30,000. Finally, Riggs Asset Managment Co. Inc. boosted its stake in Intuitive Surgical by 84.2% during the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock worth $38,000 after buying an additional 32 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of several research reports. Sanford C. Bernstein increased their target price on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Truist Financial upped their price objective on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research report on Thursday, December 18th. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Raymond James Financial raised their target price on shares of Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Finally, Argus decreased their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.86.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $493.53 on Tuesday. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $603.88. The company has a market cap of $175.27 billion, a PE ratio of 62.55, a price-to-earnings-growth ratio of 3.78 and a beta of 1.66. The stock’s 50 day moving average price is $520.00 and its 200 day moving average price is $512.68.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the prior year, the business posted $2.21 earnings per share. Intuitive Surgical’s revenue was up 18.8% compared to the same quarter last year. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other news, SVP Patricia L. Wadors sold 220 shares of the stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Mark Brosius sold 4,500 shares of the firm’s stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the sale, the senior vice president owned 907 shares of the company’s stock, valued at $496,455.52. This trade represents a 83.23% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 37,261 shares of company stock valued at $19,690,721. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.